Skip to content

Development, evaluation and intervention mechanism of resilience reconstruction model in women with breast cancer

Development, evaluation and intervention mechanism of resilience reconstruction model in women with breast cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031827
Enrollment
Unknown
Registered
2020-04-11
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

experimental group:RRM and routine nursing care
control group:routine nursing care

Sponsors

Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Women; 3. The patients who were diagnosed as primary breast cancer by histopathological and pathological diagnosis and knew the disease condition; 4. According to the 8th edition of TNM classification and staging standard for breast cancer, which was jointly formulated by AJCC and UICC in 2017, it belongs to 0-IV stage; 5. Patients who voluntarily participate in the study and are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors and dysfunction of heart, liver, lung, kidney and other important organs; 2. Patients with active infection or other serious potential infection; 3. Patients who are definitely diagnosed as psychosis; 4. Patients who have serious consciousness disorder and are unable to communicate with each other in oral and written language.

Design outcomes

Primary

MeasureTime frame
health-related quality of life;

Secondary

MeasureTime frame
resilience;life attitudes;coping styles;

Countries

China

Contacts

Public ContactKaina Zhou

Xi'an Jiaotong University

zhoukaina@mail.xjtu.edu.cn+86 15829362648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026